Biomimetic Therapeutics (BMTI) Return on Equity ROE from the third quarter 2012 to third quarter 2011 and annually, average high and low, overall ranking from Sep 30 2012 to Sep 30 2011 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biomimetic Therapeutics, Inc.  (BMTI)

Biomimetic Therapeutics's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Biomimetic Therapeutics in the third quarter 2012?
Biomimetic Therapeutics, Inc. recorded a cumulative net loss of $-17 million during 12 months ending in the third quarter 2012, resulting in a negative return on equity (ROE) of -36.99%.

Within the Medical Equipment & Supplies industry Biomimetic Therapeutics, Inc. achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the second quarter 2012 at no. .

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2012)
III. Quarter		 (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Dec 31 2011)
IV. Quarter		 (Sep 30 2011)
III. Quarter
Y / Y Equity Change -37.49 % -37.47 % -41.28 % - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -17 -20 -21 -23 -31
Return On Equity (TTM) -36.99 % -37.65 % -36.61 % -34.67 % -57.81 %
BMTI's Total Ranking # # # # #
Equity (TTM) in Millions 39 43 49 54 63
Seq. Equity Change -8.93 % -11.6 % -9.63 % -14.08 % -8.9 %
Seq. Net Income Change - - - - -

Back to BMTI Management Effectiveness >> BMTI's 5 Years Annual ROE >> Compare BMTI ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





BMTI Annual Return On Equity (Dec 31 2011)
2011



Total Equity in Millions 54 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -33 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -61.45 % - - - -

Back to BMTI Management Effectiveness >> BMTI's 5 Years Annual ROE >> Compare BMTI ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BMTI's' Return on Equity at Yahoo Finance
BMTI's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BMTI's Competitors
Subscribers only: Roe for Biomimetic Therapeutics's Suppliers
Subscribers only: Return On Equity for BMTI's Customers




Companies with similar Return On Equity at Sep 30 2012, within Healthcare Sector ROE

Date modified: 2026-09-08T15:07:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.